RESPONSE BIOMEDICAL CORP Deferred Tax Assets, Valuation Allowance

RESPONSE BIOMEDICAL CORP Deferred Tax Assets, Valuation Allowance

RESPONSE BIOMEDICAL CORP had Deferred Tax Assets, Valuation Allowance of CAD 25.61 million as of 2015-12-31, per its 10-K filed 2016-03-24.

Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2016-03-24

• 2015-12-31: Deferred Tax Assets, Valuation Allowance 25.61M CAD.
• 2014-12-31: Deferred Tax Assets, Valuation Allowance 26.78M CAD.
• 2013-12-31: Deferred Tax Assets, Valuation Allowance 25.70M CAD.
• 2012-12-31: Deferred Tax Assets, Valuation Allowance 24.68M CAD.